Type 2 & other diabetes

Safety and effectiveness of iGlarLixi in adults with type 2 diabetes mellitus from Gulf countries during Ramadan holy month: A subgroup analysis of the SoliRam observational study

Diabetes Res Clin PractPublished Subgroup analysis of the SoliRam prospective observational study

Authors' conclusion

iGlarLixi is an effective and well-tolerated treatment in people with T2DM from Gulf countries, including during Ramadan fasting, and is associated with low risk of hypoglycemia.

Study context

Population
Adults with T2D observing fast during Ramadan, Gulf countries; mean age 58.1 years, 54.4% male, mean diabetes duration 13.3 years234 eligible followed in Ramadan
Participants
241 adults
Primary endpoint
Proportion of participants with ≥1 episode of severe and/or symptomatic documented (<70 mg/dL [<3.9 mmol/L]) hypoglycemia
Follow-up
Fasting hours during Ramadan
Methodological detailsplanned subgroup analysis, multinational, non-interventional, real-world
  • Planned subgroup analysis
  • Multinational
  • Non-interventional
  • Real-world

Primary result

As reported in the abstract

≥1 episode of severe and/or symptomatic documented (<70 mg/dL [<3.9 mmol/L]) hypoglycemia during fasting hours · Ramadan

Participants with primary endpoint during fasting hours during Ramadan

1

0.5%

Further findings

Fasting during Ramadan

Participants who broke fast due to hypoglycemia
0
All 234 eligible participants fasted ≥25 days

HbA1c change · pre- to post-Ramadan

Mean ± SD change in HbA1c
−1.0 ± 1.0% [−11 ± 10 mmol/mol]

FPG change · pre- to post-Ramadan

Mean ± SD change in FPG
−22.5 ± 29.7 mg/dL

Body weight change · pre- to post-Ramadan

Mean ± SD change in body weight
−1.5 ± 2.0 kg

Safety

Adverse events

Adverse event (AE) of any cause
3 (1.2 %)
Gastrointestinal AE
1 (0.4%)

Original publication

Safety and effectiveness of iGlarLixi in adults with type 2 diabetes mellitus from Gulf countries during Ramadan holy month: A subgroup analysis of the SoliRam observational study. Diabetes Res Clin Pract. Published 9 February 2024. doi:10.1016/j.diabres.2024.111567

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.